IMMUNOONE
LIVE

Serial Number

79361819

Owner

OncoOne Research & Development GmbH

Attorney

Michael Fedrick

Filing Date

Dec 20, 2022

Add to watchlist:

No watchlists yet
View on USPTO

IMMUNOONE Trademark

Serial Number: 79361819 • Registration: 7204166

IMMUNOONE is a trademark filed by OncoOne Research & Development GmbH on December 20, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

OncoOne Research & Development GmbH (5 trademarks)

Höhenstraße 19/2

Entity Type: 99

Trademark Details

Filing Date

December 20, 2022

Registration Date

October 31, 2023

Published for Opposition

August 15, 2023

Goods & Services

Pharmaceutical, medical and veterinary preparations for the treatment of hyperproliferative and inflammatory diseases; pharmaceutical, medical and veterinary preparations comprising antibodies, antibody derivatives, and antigen binding fragments for the treatment of hyperproliferative and inflammatory diseases

Scientific and technological services and research, namely, scientific research, analysis and testing in the field of diseases using antibodies, antibody derivatives and antigen binding fragments; scientific and technological services and research in the nature of scientific research for the treatment and prevention of diseases using antibodies, antibody derivatives, and antigen binding fragments; analytical and research services; analytical scientific research and medical and scientific research services, namely, descriptive, diagnostic, predictive and prescriptive analytics for the treatment and prevention of disease using antibodies, antibody derivatives, and antigen binding fragments; pharmaceutical and biotechnological research and development; biotechnological research services

Medical and veterinary services, namely, services for the treatment and prevention of diseases using antibodies, antibody derivatives, and antigen binding fragments

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Nov 21, 2025 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 27, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 6, 2024 FICS
FINAL DISPOSITION PROCESSED
Feb 6, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 31, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 31, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 31, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 15, 2023 NPUB
PUBLISHED FOR OPPOSITION
Aug 15, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 26, 2023 NONP
WITHDRAWN FROM PUB - OG REVIEW QUERY
Jul 11, 2023 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 27, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 26, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 26, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 26, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 26, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 15, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 14, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 14, 2023 TROA
REFUSAL PROCESSED BY IB
May 31, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 5, 2023 RFCS
REFUSAL PROCESSED BY MPU
May 5, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 17, 2023 RFCR
NON-FINAL ACTION WRITTEN
Mar 16, 2023 CNRT
ASSIGNED TO EXAMINER
Mar 14, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 10, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 6, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 3, 2023 REPR